Tristel Regulatory News (TSTL)

24 May 2006 11:10

Tristel PLC24 May 2006 Tristel plc 24 May 2006 Director/PDMR Shareholding Tristel plc ("Tristel"), the healthcare business which uses its proprietarychlorine dioxide chemistry to create infection control products for hospitalsannounces the following share purchases by directors: On 23 May 2006 Paul Swinney (Chief Executive) acquired 2,500 shares at 48 penceeach and 2,500 at 54 pence each, taking his total shareholding to 2,718,986shares (11.4%). On 23 May 2006 Peter Stephens (Non-Executive Director) acquired 2,500 shares at53.5 pence each and 12,500 at 50 pence each, taking his total shareholding to548,937 shares (2.3%). ENDS Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance DirectorTel: 01638 721500 Tel 020 7786 9600http://www.tristel.com Mob: 07980 541 893 This information is provided by RNS The company news service from the London Stock Exchange